Abstract
Background
Tension homology deleted on chromosome ten (PTEN) is important in liver fibrosis.
Aims
The purpose of this study was to evaluate the PTEN gene effects and mechanism of action on hepatic stellate cells (HSCs).
Methods
The rat primary HSCs and human LX-2 cells were transfected by an adenovirus containing cDNA constructs encoding the wild-type PTEN (Ad-PTEN), the PTEN mutant G129E gene (Ad-G129E) and RNA interference targeting the PTEN sequence PTEN short hairpin RNA (PTEN shRNA), to up-regulate and down-regulate PTEN expression, respectively. The HSCs were assayed with a fluorescent microscope, real time PCR, Western blot, MTT, flow cytometry and Terminal-deoxynucleoitidyl transferase mediated nick end labeling. In addition, the CCl4 induced rat hepatic fibrosis model was also established to check the in vivo effects of the recombinant adenovirus with various levels of PTEN expression.
Results
The data have shown that the over-expressed PTEN gene led to reduced HSCs activation and viability, caspase-3 activity and cell cycle arrest in the G0/G1 and G2/M phases, as well as negative regulation of the PI3K/Akt and FAK/ERK signaling pathways in vitro. The over-expressed PTEN gene improved liver function, inhibited proliferation and promoted apoptosis of HSCs both in vitro and in vivo.
Conclusions
These data have shown that gene therapy using the recombinant adenovirus encoding wild-type PTEN inhibits proliferation and induces apoptosis of HSCs, which is a potential treatment option for hepatic fibrosis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Hepatic fibrosis results from chronic liver injury and is considered to be reversible; however, the resulting end stage cirrhosis is irreversible and can cause additional complications, as well as high mortality [1, 2]. Hepatic stellate cells (HSCs) activate and proliferate under fibrogenic conditions and are believed to be the major source of resident myofibroblasts in the fibrotic liver [3–5]. With the appearance of characteristic activation marker alpha-smooth muscle actin (α-SMA), the HSCs become active and increase the synthesis and deposition of ECM components in the liver [6]. Therefore, HSCs are an attractive target for anti-fibrotic therapy [7, 8].
Phosphatase and tension homolog deleted on chromosome ten (PTEN), the first tumor-suppressing gene found to have dual protein/lipid phosphatase activity, negatively regulates the cell cycle, decreases cell proliferation and promotes apoptosis of tumor cells [9–12]. Earlier PTEN studies have focused on non-tumor diseases and have shown that PTEN inhibits proliferation and induces apoptosis of lung fibroblasts in vitro [13, 14], while the lower expression of PTEN can also cause renal fibrosis [15]. The absence of PTEN in specific hepatic cells may result not only in hepatocellular carcinoma, but also in nonalcoholic steatohepatitis, which has been found to be closely associated with hepatic fibrosis [16].
Our previous study has shown that PTEN expression decreased in fibrotic rat hepatic tissues induced by bile duct ligation (BDL) [17]. During the reversal of liver fibrosis pretreated by CCl4, the PTEN mRNA and protein expression returned to almost normal levels, showing a connection between PTEN and the stage of rat hepatic fibrosis [18]. However, the mechanism of PTEN gene effects on proliferation and apoptosis of primary HSCs remains unclear.
This study was designed to investigate the effects of over-expressed PTEN on proliferation, apoptosis and cell cycle of HSCs in vitro and in vivo, which may provide a new strategy for prevention and treatment of liver fibrosis.
Materials and Methods
Animals
Adult male Wistar rats, 8 weeks old and weighing 350–400 g, were obtained from the Experimental Animal Center of the Hebei Medical University. The whole experiment was performed in compliance with the national ethical guidelines for the care and use of laboratory animals, following internationally accepted principles of laboratory animal use and care defined in US guidelines (NIH publication #85-23, revised in 1985).
Rat Primary HSCs Isolation and Cell Culture
Rat primary HSCs were isolated from normal healthy male Wistar rats using in situ recirculating perfusion technology, as described [19]. The cells were then cultured in DMEM with 10 % FBS. The first medium change was performed at 24 h post-isolation. The cells were passaged at days 15 and 25 post-isolation and the second passage was used for transfection. The purification degree of primary HSCs at passage 2 was higher than 95 %.
Human LX-2 cells were obtained from the Mount Sinai School of Medicine.
Recombinant Adenovirus and Transfection
The adenovirus containing cDNA constructs encoding wild-type PTEN (Ad-PTEN) with a green fluorescent protein (GFP), the PTEN mutant G129E gene (Ad-G129E) with GFP and the empty virus control (Ad-GFP) were provided by Prof. Junshan Zhu from the Third Military Medical University in China. The RNA interference targeting PTEN sequence, and the PTEN short hairpin RNA (shRNA) with enhanced green fluorescent protein (EGFP) was established by Wuhan Genesil Biotechnology Co., Ltd (Wuhan, China). The transfection was performed as described [20] and confirmed by demonstrating GFP expression in rat primary HSCs. The infection efficiency of the adenovirus was determined using fluorescence microscopy and flow cytometry (data not shown). For optimal transfection, we used the MOI 50 for 72 h (rat primary HSCs infection efficiency: 94.46 %; human LX-2 cells infection efficiency: 89.89 %).
The rat primary HSCs and human LX-2 cells were divided into five groups: (1) the control group, antibiotics-free DMEM; (2) the Ad-GFP group, with Ad-GFP transfection; (3) the Ad-PTEN group, with Ad-PTEN transfection; (4) the Ad-G129E group, with Ad-G129E transfection; and (5) the PTEN shRNA group, with PTEN shRNA transfection.
Real Time PCR
Real time PCR was performed as previously described [18, 21]. Primer Express 5.0 was used to design the following primers: PTEN (rat) Forward 5′-GGA AAG GAC GGA CTG GTG TA-3′, Reverse 5′-GGA AAG GAC GGA CTG GTG TA-3′; PTEN (human) Forward 5′-ACC GCC AAA TTT AAT TGC AG-3′, Reverse 5′-GGG TCC TGA ATT GGA GGA AT-3′; PI3K (rat) Forward 5′-ACT TTG TGA CCT TCG GCT TT-3′, Reverse 5′-TAC ATT CCT GAT CTT CCT CG-3′; PI3K (human) Forward 5′-TGC CTC CAC GAC CAT CAT CA-3′, Reverse 5′-TTC ACA CAC TGG CAT GCC GA-3′; Akt (rat) Forward 5′-GAG GAG CGG GAA GAG TG-3′, Reverse 5′-GAG ACA GGT GGA AGA AGA GC-3′; Akt (human) Forward 5′-CAT CAC ACC ACC TGA CCA AG-3′, Reverse 5′-CTC AAA TGC ACC CGA GAA AT-3′; FAK (rat) Forward 5′-ACT TGG ACG CTG TAT TGG AG-3′, Reverse 5′-CTG TTG CCT GTC TTC TGG AT-3′; FAK (human) Forward 5′-GCG TCT AAT CCG ACA GCA-3′, Reverse 5′-GCC GAC TTC CTT CAC CAT-3′; ERK1 (rat) Forward 5′-TCA TAG GCA TCC GAG ACA TC-3′, Reverse 5′-TGG TAG AGG AAG TAG CAG ATG-3′; ERK1 (human) Forward 5′-GAT GGG GCA GTA CAA GGA GA-3′, Reverse 5′-TGC AGT GGA TAG AGC ACC AG-3′; Rat collagen α1 (I) Forward: 5′-CAG GCT GGT GTG ATG GGA TT-3′, Reverse 5′-CCA AGG TCT CCA GGA ACA CC-3′; GAPDH (rat) Forward 5′-GGC AAG TTC AAC GGC ACA G-3′, Reverse 5′-CGC CAG TAG ACT CCA CGA CAT-3′; GAPDH (human) Forward 5′-ACT TTG GTA TCG TGG AAG GAC T-3′, Reverse 5′-GTA GAG GCA GGG ATG ATG TTC T-3′. The primers were synthesized by SBS Genetech Co., Ltd (Beijing, China). Relative mRNA expression was measured according to the method of fold increase (2−△△Ct).
Western Blot Assay
Total protein was isolated either from the HSCs at 72 h post-infection or from the liver tissue of sacrificed rats. Western blotting was performed as previously described [17]. The anti-PTEN (Santa Cruz, USA), anti-Bcl-2 (Santa Cruz, USA), anti-Bax (Santa Cruz, USA), anti-CyclinD1 (Santa Cruz, USA), anti-CDK4 (Santa Cruz, USA), anti-P27kip1 (eBioscience, USA), anti-Akt (eBioscience, USA), anti-p-AktThr308 (eBioscience, USA), anti-FAK (Santa Cruz, USA), anti-pFAKTyr397 (Santa Cruz, USA), anti-ERK1 (Santa Cruz, USA), anti-pERK1 (Santa Cruz, USA) (1:200) and anti-GAPDH antibodies (Santa Cruz, USA) (1:500) were used as primary antibodies. The blots were developed using enhanced chemiluminescene (ECL).
The results were analyzed with Kodak 1D digital imaging software (Kodak, USA) and reported as the optical density ratio of the target protein to GAPDH.
Cell Proliferation Assay with MTT
The MTT assay was performed as described previously [21]. Briefly, the HSCs were seeded into a 96-well plate at a density of 3 × 104/mL × 200 μL/well. Adenoviral gene transfection was performed as described above. At 24, 48 and 72 h post-infection, the MTT solution of 5 mg/mL × 20 μL/well was added to the wells. The cells were allowed to grow for 4 h and then the medium was replaced with 150 μL dimethylsulfoxide (DMSO). The absorbance (A), measured at 490 nm, was used to calculate the inhibition rate of proliferation [(A control − A experimental)/A control × 100 %].
Apoptosis Assay by FAC and TUNEL
The cultured HSCs were analyzed by FAC and terminal-deoxynucleoitidyl transferase mediated nick end labeling (TUNEL) analysis to assay apoptosis, as previously described [21]. The double immunofluorescent staining of TUNEL and α-SMA was also done to study the apoptotic index of activated HSCs in vitro and in vivo [18].
Caspase-3 Activity Assay
We used the caspase activity assay kit from Beyotime Institute of Biotechnology (China) to measure caspase-3 activity, according to manufacturer’s instructions. Briefly, 5 × 104 HSCs/mL were seeded into each well in a 6-well plate and infected by the corresponding virus. The cells were harvested and lysed for 15 min on ice in a ratio of 200,000 cells to 100 µL of the lysis buffer. Protein concentration was measured using the Bradford assay kit to determine the suitable amount of protein for the next step. In a 96-well plate, 80 µL of detection buffer + 10 µL sample + 10 µL Ac-DEVD-pNA was added into each well at 37 °C for 4 h. Then A405 was measured to determine caspase-3 activity.
Cell Cycle Assay by FAC
A total of 5 × 104 HSCs/mL were seeded into each well in a 6-well plate and infected by the virus. The cells were harvested and adjusted to 1 × 106/mL using 1 × PBS. Then, 100 μL of this cell solution were added to 1 mL of the PI buffer in the dark, at 4 °C, for 30 min. The cell solution was filtered before acquiring the data. Chicken erythrocytes also underwent the same process. The data was analyzed using Expo 32 ADC and Muticycle AV.
Animal Model
CCl4-induced rat hepatic fibrosis was established as described previously [18]. Recombinant adenovirus (2 × 109 pfu/100 μL/rat) was introduced by injecting the tail vein of the rats once per week, starting at the fourth week post-administration of CCl4 and lasting for 4 weeks. Recombinant adenoviruses used in the in vivo experiment were Ad-GFP, Ad-PTEN, Ad-G129E and PTEN shRNA; the CCl4 only-treated rats were used as the control.
Pathology, Immunohistochemical and Immunofluorescent Staining of the Liver Tissue
Postmortem, the liver was removed and liver sections were processed routinely. Hematoxylin-eosin (H&E) staining was performed to assess the degree of inflammation and Masson’s trichrome (MT) staining was performed to assess collagen deposition. Histopathological scores of the liver were assigned in a blinding manner by two well-trained pathologists—inflammation was graded according to the histology activity index (HAI-Knodell score) as Knodell [22]; fibrosis in the liver was analyzed by the Masson-stained area as percentage of the total area using ImageJ 2, as previously described [23]. To check the expression changes of PTEN in the liver tissue and HSCs in vivo, immunofluorescent staining was also performed on frozen liver sections, as described [18].
Statistical Analysis
The data were presented as the mean ± SD and analyzed with SPSS 18.0 software. One-way ANOVA, the Student–Newman–Keulsthe (SNK-q) test and the Student’s t test were performed. P < 0.05 was considered to indicate a statistically significant difference.
Results
Effect of the PTEN Gene Expression on Proliferation of HSCs
The MTT results have shown that the wild-type PTEN and G129E genes were able to significantly inhibit the proliferation and viability of both rat primary HSCs (74.71 %) and human LX-2 cells (50.43 %) (Fig. 1a), while PTEN shRNA significantly enhanced the viability (118.26 vs 142.15 %) in comparison to the control group, P < 0.01 (Fig. 1a).
The BrdU assay was also used to check HSCs proliferation. At 72 h post-transfection, the DNA synthesis of primary HSCs and human LX-2 cells was significantly reduced in Ad-PTEN (63.32 vs 42.38 %) and Ad-G129E (74.75 vs 56.65 %) groups, compared to the Ad-GFP group (P < 0.01); whereas PTEN shRNA enhanced the DNA synthesis of rat primary HSCs by 35.36 %, P < 0.01, and human LX-2 cells by 57.13 %, P < 0.01 (Table 1).
Effect of PTEN Gene Expression on Apoptosis of HSCs
To further assess the regulation of the PTEN gene on HSCs, flow cytometry was performed using combined marked Annexin-V/PE to check the apoptosis of rat primary HSCs and human LX-2 cells. At 72 h post-transfection, significantly higher apoptotic rates of rat primary HSCs and human LX-2 cells were found in the Ad-PTEN (34.85 ± 2.11 vs 41.76 ± 1.98 %) and Ad-G129E (25.18 ± 1.34 vs 37.18 ± 2.13 %) groups in comparison to the control (3.12 ± 0.15 vs 5.68 ± 1.15 %) and Ad-GFP (4.21 ± 0.35 vs 7.21 ± 1.25 %) groups, with P < 0.01. In addition, significantly lower apoptotic rates were found in the PTEN shRNA group (1.24 ± 0.08 vs 2.25 ± 1.18 %) in comparison to the control and Ad-GFP groups, P < 0.01 (Fig. 1b). Additionally, TUNEL was also performed to double check the apoptosis of HSCs; similar results were found as in the case of Annexin-V staining assessed by flow cytometry (Fig. 1c).
To further investigate the mechanism of PTEN-induced HSCs apoptosis, we used Western blotting to check the expression of apoptosis-associated proteins and found that the expression of the Bcl-2 protein was decreased significantly in comparison to the control and Ad-GFP groups (P < 0.01). On the contrary, Bax protein expression significantly increased compared to the control and Ad-GFP groups (P < 0.01) by over-expression of the wild-type PTEN gene or G129E gene in rat primary HSCs and human LX-2 cells, with an enhanced ratio of Bax/Bcl-2 as well. Down-regulated PTEN expression in the PTEN shRNA group showed a completely opposite effect on Bcl-2 and Bax (Fig. 1d, e).
Effect of PTEN Gene Expression on Caspase-3 Activity in HSCs
Over-expression of the wild-type PTEN gene and G129E gene significantly promoted the activity of caspase-3 in rat primary HSCs (2.16- vs 1.73-fold), P < 0.01, while, on the contrary, PTEN shRNA inhibited the activity of caspase-3 compared to the Ad-GFP group (P < 0.05). Similar results were also found in human LX-2 cells (Table 2).
Modulation of Cell Cycle by PTEN Gene Expression
Flow cytometry was used to check the cell cycles of rat primary HSCs and human LX-2 cells. A significantly greater number of cells was found in the G0/G1 phase in the Ad-PTEN (70.56 ± 4.05 vs 71.84 ± 2.15 %) and Ad-G129E (67.42 ± 2.15 vs 64.12 ± 1.25 %) groups, in comparison to the Ad-GFP group (58.78 ± 1.11 vs 56.37 ± 1.12 %), P < 0.01; while a significantly lower number of cells was found in the PTEN shRNA group (35.46 ± 3.05 vs 37.98 ± 2.13 %), P < 0.01. In the S phase, in comparison to the Ad-GFP group, significantly lower numbers of rat primary HSCs and human LX-2 cells were found in the Ad-PTEN (10.25 ± 1.04 vs 10.56 ± 1.15 %) and Ad-G129E (12.11 ± 1.05 vs 13.12 ± 3.12 %) groups in comparison to the Ad-GFP group (15.55 ± 1.74 vs 16.21 ± 2.13 %), P < 0.01; while a significantly lower number of cells was observed in the PTEN shRNA group (21.17 ± 2.94 vs 33.34 ± 2.15 %), P < 0.01. Cells in the G2/M phase were also studied and found to be similar as cells in the S phase (Fig. 2a). These data indicated that both rat primary HSCs and human LX-2 cells were arrested in the G0/G1 and G2/M phase by wild-type PTEN gene and G129E gene, while the PTEN shRNA acted as a promoter in this phase of the cell cycle.
To further investigate the mechanism of PTEN gene modulation on HSCs cell cycles, we detected several cell cycle-related protein expressions in rat primary HSCs and human LX-2 cells. We found significantly down-regulated CyclinD1 (29.07 vs 15.12, 38.79 vs 19.31 %) and CDK4 (42.96 vs 34.51, 33.67 vs 27.55 %) expression in the Ad-PTEN and Ad-G129E groups and significantly up-regulated P27kip1 expression (63.16 vs 38.10, 67.37 vs 45.26 %) compared to Ad-GFP group (P < 0.01), while the PTEN shRNA had an opposite effect (Fig. 2b, c).
Signaling Transduction Mechanisms of PTEN in Behavior Regulation of HSCs
Western blotting has shown that, in rat primary HSCs, both PI3K and p-AktThr308 protein expression significantly decreased in the Ad-PTEN group (0.49 ± 0.02 vs 0.28 ± 0.02), in comparison with the Ad-G129E (0.75 ± 0.06 vs 0.48 ± 0.03), control (0.82 ± 0.07 vs 0.50 ± 0.02) and Ad-GFP (0.79 ± 0.03 vs 0.52 ± 0.05) groups (P < 0.01), while both of them showed opposite expressions in the PTEN shRNA group (1.12 ± 0.14 vs 0.62 ± 0.03) (Fig. 3a, b). A similar tendency was also found in experiments with human LX-2 cells (Fig. 3a, c). Real-time PCR was also used to check the changes in mRNA in primary HSCs. Expression of the control group was arbitrarily assigned a value of 1; then the PI3K mRNA relative expression levels in Ad-GFP, Ad-PTEN, Ad-G129E and PTEN shRNA groups were calculated to be 0.979-, 0.716-, 0.962- and 1.223-fold, respectively (Fig. 3d). Similar results were found in human LX-2 cells (Fig. 3e); however, no significant differences were found in the Akt mRNA expressions (Fig. 3d, e). The data indicated that PTEN may regulate HSCs behavior via the PI3K/Akt signaling pathway.
We then found that both p-FAKTyr397 and p-ERK1 protein expression in rat primary HSCs significantly decreased in the Ad-PTEN (0.42 ± 0.05 vs 0.25 ± 0.02) and Ad-G129E (0.49 ± 0.07 vs 0.28 ± 0.07) groups in comparison with the control (0.80 ± 0.09 vs 0.54 ± 0.07) and Ad-GFP (0.78 ± 0.05 vs 0.52 ± 0.06) groups (P < 0.01), while it significantly increased in the PTEN shRNA group (0.92 ± 0.07 vs 0.70 ± 0.05), P < 0.01 (Fig. 3a, b). A similar tendency was also found in experiments with human LX-2 cells (Fig. 3a, c). However, no significant differences were found in mRNA expressions of FAK and ERK (Fig. 3d, e). The data indicated that PTEN may regulate HSCs behavior via the FAK/ERK signaling pathway.
The Role of PTEN on CCl4-Induced Rat Liver Fibrosis and the Activation of HSCs In Vivo
With the overexpressed PTEN gene in the Ad-PTEN and Ad-G129E groups, biochemical index analyses have shown that the over-expression of the PTEN gene in the Ad-PTEN and Ad-G129E groups could improve liver function by significantly reducing the serum levels of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), in comparison to the CCl4 group, control group and Ad-GFP group. However, the PTEN shRNA had the opposite effect (Table 3).
The hematoxylin and eosin (H&E) stain and the Masson’s trichrome (MT) stain confirmed that the over-expressed PTEN gene in the Ad-PTEN and Ad-G129E groups reduced the hepatic cell necrosis, as well as liver inflammation (Fig. 4a, b) and also decreased collagen deposition in liver tissue (Fig. 4a, c). The mRNA of collagen α1 (I) was further checked by real-time PCR and has shown a similar tendency (Fig. 4d). To explore whether improved pathology was due to the changes in PTEN expression, we performed immunofluorescent staining for PTEN in green and α-SMA in red; the yellow color from the co-localization showed that the PTEN+HSCs, which mainly existed in the cytoplasm of activated HSCs, and the activated HSCs expressing PTEN, accounted for a decreasing percentage of total activated HSCs. This observation indicated that the over-expression of PTEN induced by exogenous wild-type PTEN and G129E genes can significantly inhibit the α-SMA expression in comparison with the Ad-GFP and CCl4 groups (Fig. 4). We found that PTEN expression significantly decreased with administration of the Ad-PTEN and Ad-G129E recombinant adenovirus, which confirmed successful infection and was evident through improved pathology (Fig. 4a).
We isolated the total protein from liver tissues in each group and performed Western blot analysis to further check the protein expressions of PTEN and α-SMA. Consistent with our previous studies, the PTEN protein expression decreased significantly due to CCl4 whereas α-SMA protein expression increased significantly due to CCl4 [18]. The PTEN protein expression increased significantly by 1.96-, 3.20-, 3.33- and 5.64-fold in the Tre 1 week, Tre 2 weeks, Tre 3 weeks and Tre 4 weeks (P < 0.01) in rats treated by Ad-PTEN (Fig. 5a). The α-SMA protein changes had an opposite effect in comparison to PTEN (Fig. 5b).
The Role of PTEN on CCl4-Induced Rat Liver Fibrosis and the Apoptosis of HSCs In Vivo
In our previous study, TUNEL was used to find that CCl4 treatment can increase the levels of apoptotically activated HSCs in comparison to normal rat liver tissue, where less apoptotically activated HSCs were detected [18]. In this experiment, the over-expression of the PTEN gene induced by exogenous wild-type PTEN and G129E genes can induce the apoptosis of activated HSCs. The ratio of apoptotically activated HSCs to total activated HSCs was described as the apoptotic index. We found a significantly increased apoptotic index in the Ad-PTEN group in Tre 1 week (65.12 ± 5.37 %), Tre 2 weeks (46.32 ± 4.26 %), Tre 3 weeks (30.16 ± 2.23 %) and Tre 4 weeks (32.14 ± 1.35 %) groups, in comparison to CCl4 and Ad-GFP groups (P < 0.01); the PTEN shRNA induced down-regulation of PTEN can caused significantly reduced apoptotic index of HSCs, P < 0.05 (Table 4).
Discussion
Liver fibrosis is reversible, however, there is no effective therapy to reverse hepatic fibrosis and stop the progression to irreversible cirrhosis [1, 2]. An increased number of myofibroblasts was found to be associated with the severity of liver fibrosis in patients [3].
PTEN is involved in the pathogenesis of myocardial, renal and lung fibrosis [14, 15, 24]. Our previous studies have found that increased PTEN expression can reduce the number of activated HSCs, negatively regulate fibrogenesis in vivo [17, 18], and induce the apoptosis of activated HSCs in vitro [20]. The activation and apoptosis of HSCs plays a key role in liver fibrogenesis [2], which shows that PTEN is a potential target for reversing liver fibrosis.
To address this question, we first isolated and purified rat primary HSCs and then performed transfection using the PTEN over-expressing recombinant adenovirus Ad-PTEN and Ad-G129E. In addition, transfection was performed with the PTEN under-expressing recombinant adenovirus PTEN shRNA and a secondary cell line, Human LX-2, was used. We found that PTEN expression was up-regulated by Ad-PTEN and Ad-G129E and down-regulated by PTEN shRNA. Increased PTEN expression led to decreased activation of HSCs and increased apoptosis of both rat primary HSCs and human LX-2 cells, which was consistent with previous findings [18, 20, 25]. This study additionally found that down-regulated PTEN expression resulted in more pronounced liver fibrosis in vivo, increased activated HSCs and decreased apoptotically activated HSCs, which indicated a protective role of PTEN in hepatic fibrosis.
The proliferation and migration of HSCs in the liver play a critical role in fibrostenosis [1]. Increased PTEN expression led to a reduction in the proliferation of HSCs in vitro, and also improved the fibrotic phenotype in CCl4-treated rats, while a decreased expression of PTEN acted oppositely. Activated HSCs rarely can return to a quiescent condition; however, the induction of apoptosis of activated HSCs is one of the major ways for liver to eliminate activated HSCs [26]. In this study, increased PTEN expression caused an increase in apoptotic HSCs, and decreased PTEN expression resulted in decreased apoptotic HSCs in both rat primary HSCs and human LX-2 cells, pointing to a pro-apoptotic role of PTEN in HSCs. The activation of caspase-3, sharing lots of typical characteristics with the other caspase, is one of the signaling pathways in HSCs apoptosis [27, 28]. To further investigate the potential mechanism of PTEN in HSCs apoptosis, caspase-3 activity was assessed. We found that increased PTEN expression led to enhanced caspase-3 activity, which was consistent with an increased apoptotic index in both rat primary HSCs and human LX-2 cells treated by Ad-PTEN and Ad-G129E. The PTEN shRNA reduced PTEN expression and down-regulated the activity of caspase-3, which was also consistent with the results that a decreased expression of the PTEN gene resulted in less apoptotic HSCs. Overall, our data have shown that PTEN can induce HSCs apoptosis, probably by regulating caspase-3 activity.
The balance of apoptosis-associated genes Bcl-2 and Bax plays an important role in cell apoptosis [29]. We found that the anti-apoptosis factor Bcl-2 increased in HSCs treated by PTEN shRNA and decreased in HSCs treated by Ad-PTEN and Ad-G129E, while its inhibitor Bax was decreased in PTEN shRNA treated HSCs and increased in Ad-PTEN and Ad-G129E treated HSCs. It was concluded that PTEN may regulate HSCs apoptosis through Bax/Bcl-2 expression.
Earlier studies have found that PTEN negatively regulates the cell cycle and inhibits the proliferation and differentiation of tumor cells [30, 31]. The question remained whether PTEN can regulate the cell cycle of HSCs based on the inhibition of activation and proliferation of HSCs from over-expressed PTEN [20]. The results have shown that high PTEN expression can arrest the HSCs cell cycle in the G0/G1 phase probably due to inhibition of the G1/S phase transformation. Moreover, the low expression of PTEN can promote the transformation of the G1/S phase. CyclinD1, a positive regulatory factor on the G1/S phase transformation, as well as CDK4, a major regulator in the cell cycle, were found to increase with down-regulation of PTEN expression. This could partially explain the mechanism of PTEN on the arrest of G0/G1 in HSCs. This finding was consistent with the negative regulatory role of PTEN on the cell cycle of tumor cells, through inhibition of CyclinD1 and CDK4 protein expressions [32, 33]. P27kip1 binds specifically to CyclinD-CDK4(CDK6), CyclinA-CDK2 and CyclinE2-CDK2, which all have an important role in the S phase. The lower level of P27kip1 cannot efficiently inhibit the cell over-proliferation and tumor progression [34]. In this study, the over-expressed PTEN gene has been shown to enhance P27kip1 expression, indicating that PTEN may negatively regulate the HSCs cell cycle through P27kip1.
The behavior of HSCs is regulated by several signal transduction pathways, such as focal adhesion kinase (FAK)/extracellular signal-regulated kinase1/2 (ERK1/2), phosphoinositol-3-kinase (PI3K)/serine–threonine protein kinase B (Akt), Ras/Raf/MEK/ERK1/2, etc. [21, 35, 36]. The PTEN was found to be involved in signaling pathways in HSCs and other types of cells [9, 10, 37–40], indicating a potential relationship between the PTEN and behavior regulation of HSCs.
The reduced expression of PTEN in this study was found to promote p-AktThr308 expression through lipid phosphatase activity in the HSCs and positively regulate PI3K/Akt signaling, leading to increased activation and decreased apoptosis of HSCs. The over-expression of PTEN can inhibit PI3K/Akt signaling. FAK, the key point in the integrin-mediated signal transduction pathway, was recently found to play a vital role in the development of fibrotic disorders [41]. We have previously shown that the decrease in FAK expression using FAK shRNA inhibited proliferation and induced the apoptosis of the rat HSCs cell line [21]. In this study, we used PTEN shRNA to achieve the reduced expression of PTEN in rat primary HSCs and human LX-2 cells, and we found increased p-FAKTyr397 and p-ERK expressions. In addition, we also detected that the over-expressed PTEN can negatively regulate the FAK/ERK signaling pathway in HSCs through the protein phosphatase activity, leading to decreased HSCs activation.
Gene therapy using the adenovirus vector is a potentially novel method of transfection efficiency with a low number of adverse effects [42–44]. In this study, the treatment of rats with CCl4-induced hepatic fibrosis with a recombinant adenovirus carrying the highly expressed PTEN gene has been shown to improve liver function, inhibit activated HSCs and induce apoptosis of active HSCs. The down-regulated PTEN can worsen hepatic fibrosis in the CCl4-induced rat model.
In conclusion, these data demonstrate that PTEN can regulate HSCs' behavior both in vitro and in vivo, probably through the FAK/ERK and PI3K/Akt signaling pathways and also through its regulation on the HSCs cell cycle and caspase-3 activity. Gene therapy using recombinant adenovirus encoding the wild-type PTEN may be a novel treatment option for hepatic fibrosis.
Abbreviations
- HSCs:
-
Hepatic stellate cells
- ECM:
-
Extracellular matrix
- α-SMA:
-
Alpha-smooth muscle actin
- PTEN:
-
Tension homology deleted on chromosome ten
- BDL:
-
Bile duct ligation
- shRNA:
-
Short hairpin RNA
- GFP:
-
Green fluorescent protein
- EGFP:
-
Enhanced green fluorescent protein
- H&E:
-
Hematoxylin and eosin
- MT:
-
Masson’s trichrome
- TUNEL:
-
Terminal-deoxynucleoitidyl transferase mediated nick end labeling
- FCM:
-
Flow cytometry
- FAK:
-
Focal adhesion kinase
- ERK:
-
Extracellular signal-regulated kinase
- PI3K:
-
Phosphoinositol-3-kinase
- Akt:
-
Serine–threonine protein kinase B
- ALT:
-
Alanine aminotransferase
- AST:
-
Aspartate aminotransferase
References
Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425–456.
Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655–1669.
Brenner DA, Kisseleva T, Scholten D, et al. Origin of myofibroblasts in liver fibrosis. Fibrogenesis Tissue Repair. 2012;5:S17.
Asahina K, Zhou B, Pu WT, Tsukamoto H. Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology. 2011;53:983–995.
Scholten D, Reichart D, Paik YH, et al. Migration of fibrocytes in fibrogenic liver injury. Am J Pathol. 2011;179:189–198.
Wasmuth HE, Weiskirchen R. Pathogenesis of liver fibrosis: modulation of stellate cells by chemokines. Z Gastroenterol. 2010;48:38–45.
Kisseleva T, Cong M, Paik Y, et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci USA. 2012;109:9448–9453.
Liu X, Xu J, Brenner DA, Kisseleva T. Reversibility of liver fibrosis and inactivation of fibrogenic myofibroblasts. Curr Pathobiol Rep. 2013;1:209–214.
Kim HA, Kim KJ, Seo KH, Lee HK, Im SY. PTEN/MAPK pathways play a key role in platelet-activating factor-induced experimental pulmonary tumor metastasis. FEBS Lett. 2012;586:4296–4302.
Shi Y, Paluch BE, Wang X, Jiang X. PTEN at a glance. J Cell Sci. 2012;125:4687–4692.
Garcia-Junco-Clemente P, Golshani P. PTEN: a master regulator of neuronal structure, function, and plasticity. Commun Integr Biol. 2014;7:e28358.
Muniyan S, Ingersoll MA, Batra SK, Lin MF. Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor. Biochim Biophys Acta. 2014;1846:88–98.
White ES, Thannickal VJ, Carskadon SL, et al. Integrin α4β1 regulates migration across basement membranes by lung fibroblasts: a role for phosphatase and tensin homologue deleted on chromosome 10. Am J Respir Crit Care Med. 2003;168:436–442.
White ES, Atrasz RG, Hu B, et al. Negative regulation of myofibroblast differentiation by PTEN (phosphatase and tensin homolog deleted on chromosome 10). Am J Respir Crit Care Med. 2006;173:112–121.
Lan R, Geng H, Polichnowski AJ, et al. PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis. Am J Physiol Renal Physiol. 2012;302:F1210–F1223.
Vinciguerra M, Veyrat-Durebex C, Moukil MA, Rubbia-Brandt L, Rohner-Jeanrenaud F, Foti M. PTEN down-regulation by unsaturated fatty acids triggers hepatic steatosis via an NF-κBp65/mTOR-dependent mechanism. Gastroenterology. 2008;134:268–280.
Hao LS, Zhang XL, An JY, et al. PTEN expression is down-regulated in liver tissues of rats with hepatic fibrosis induced by biliary stenosis. APMIS. 2009;117:681–691.
Zheng L, Chen X, Guo J, et al. Differential expression of PTEN in hepatic tissue and hepatic stellate cells during rat liver fibrosis and its reversal. Int J Mol Med. 2012;30:1424–1430.
Ma J, Li F, Liu L, et al. Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells. Liver Int. 2009;29:567–574.
Hao LS, Zhang XL, An JY, et al. Adenoviral transduction of PTEN induces apoptosis of cultured hepatic stellate cells. Chin Med J (Engl). 2009;122:2907–2911.
An J, Zheng L, Xie S, et al. Down-regulation of focal adhesion kinase by short hairpin RNA increased apoptosis of rat hepatic stellate cells. APMIS. 2011;119:319–329.
Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic hepatitis. Hepatology. 1981;1:431–435.
Wang Y, Gao J, Zhang D, et al. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol. 2010;53:132–144.
Singla DK. Akt-mTOR pathway inhibits apoptosis and fibrosis in doxorubicin-induced cardiotoxicity following embryonic stem cell transplantation. Cell Transplant. 2015;24:1031–1042.
Takashima M, Parsons CJ, Ikejima K, Watanabe S, White ES, Rippe RA. The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation. J Gastroenterol. 2009;44:847–855.
Povero D, Busletta C, Novo E, et al. Liver fibrosis: a dynamic and potentially reversible process. Histol Histopathol. 2010;25:1075–1091.
Che XH, Jiang WY, Parajuli DR, Zhao YZ, Lee SH, Sohn DH. Apoptotic effect of propyl gallate in activated rat hepatic stellate cells. Arch Pharm Res. 2012;35:2205–2210.
Li J, Li X, Xu W, et al. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6 K and TGFβ/Smad signalling pathways. Liver Int. 2015;35:1222–1233.
Marin JJ, Hernandez A, Revuelta IE, et al. Mitochondrial genome depletion in human liver cells abolishes bile acid-induced apoptosis: role of the Akt/mTOR survival pathway and Bcl-2 family proteins. Free Radic Biol Med. 2013;61:218–228.
Van Duijn PW, Ziel-van der Made AC, van der Korput JA, Trapman J. PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulators. Prostate. 2010;70:135–146.
Paul-Samojedny M, Suchanek R, Borkowska P, et al. Knockdown of AKT3 (PKBγ) and PI3KCA suppresses cell viability and proliferation and induces the apoptosis of glioblastoma multiforme T98G cells. Biomed Res Int. 2014;2014:768181.
Aarts M, Linardopoulos S, Turner NC. Tumour selective targeting of cell cycle kinases for cancer treatment. Curr Opin Pharmacol. 2013;13:1–7.
Chung JH, Ostrowski MC, Romigh T, Minaguchi T, Waite KA, Eng C. The ERK1/2 pathway modulates nuclear PTEN-mediated cell cycle arrest by cyclin D1 transcriptional regulation. Hum Mol Genet. 2006;15:2553–2559.
Mitrea DM, Yoon MK, Ou L, Kriwacki RW. Disorder-function relationships for the cell cycle regulatory proteins p21 and p27. Biol Chem. 2012;393:259–274.
Brenner DA. Molecular pathogenesis of liver fibrosis. Trans Am Clin Climatol Assoc. 2009;120:361–368.
Wang J, Xu F, Zhu D, et al. Schistosoma japonicum soluble egg antigens facilitate hepatic stellate cell apoptosis by downregulating Akt expression and upregulating p53 and DR5 Expression. PLoS Negl Trop Dis. 2014;8:e3106.
Zhang S, Yu D. PI(3)king apart PTEN’s role in cancer. Clin Cancer Res. 2010;16:4325–4330.
Ming M, Han W, Maddox J, et al. UVB-induced ERK/AKT-dependent PTEN suppression promotes survival of epidermal keratinocytes. Oncogene. 2010;29:492–502.
Bunney TD, Katan M. Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat Rev Cancer. 2010;10:342–352.
Dubrovska A, Kim S, Salamone RJ, et al. The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci USA. 2009;106:268–273.
Lagares D, Kapoor M. Targeting focal adhesion kinase in fibrotic diseases. BioDrugs. 2013;27:15–23.
Podolska K, Stachurska A, Hajdukiewicz K, Malecki M. Gene therapy prospects-intranasal delivery of therapeutic genes. Adv Clin Exp Med. 2012;21:525–534.
Sakashita M, Mochizuki S, Sakurai K. Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry. Bioorg Med Chem. 2014;22:5212–5219.
Baertsch MA, Leber MF, Bossow S, et al. MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus. Cancer Gene Ther. 2014;21:373–380.
Acknowledgments
This work was supported by the National Natural Science Foundation of China (Grant 30872513), Natural Science Foundation of Hebei Province (Grant C2010000565), and Hebei Provincial Science and Technology Department (Grant 09966108D). The authors would like to thank the foundations for their support. We appreciate Gregory X Shen for his valuable revision of written English and owe many thanks to Hong Zhang and Jinbo Guo for their photo contributions.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared no conflict of interest.
Additional information
Junyan An and Libo Zheng have contributed equally to this work.
Rights and permissions
About this article
Cite this article
An, J., Zheng, L., Xie, S. et al. Regulatory Effects and Mechanism of Adenovirus-Mediated PTEN Gene on Hepatic Stellate Cells. Dig Dis Sci 61, 1107–1120 (2016). https://doi.org/10.1007/s10620-015-3976-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-015-3976-2